BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21610314)

  • 1. Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2.
    Coma S; Shimizu A; Klagsbrun M
    Cell Adh Migr; 2011; 5(3):266-75. PubMed ID: 21610314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis.
    Zhang B; Gao Z; Sun M; Li H; Fan H; Chen D; Zheng J
    J Surg Oncol; 2015 Mar; 111(4):382-8. PubMed ID: 25475162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration.
    Favier B; Alam A; Barron P; Bonnin J; Laboudie P; Fons P; Mandron M; Herault JP; Neufeld G; Savi P; Herbert JM; Bono F
    Blood; 2006 Aug; 108(4):1243-50. PubMed ID: 16621967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of mTOR Signaling by Semaphorin 3F-Neuropilin 2 Interactions In Vitro and In Vivo.
    Nakayama H; Bruneau S; Kochupurakkal N; Coma S; Briscoe DM; Klagsbrun M
    Sci Rep; 2015 Jul; 5():11789. PubMed ID: 26156437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis in the B-neuropilin-2 domain selectively enhances its affinity to VEGF165, but not to semaphorin 3F.
    Geretti E; Shimizu A; Kurschat P; Klagsbrun M
    J Biol Chem; 2007 Aug; 282(35):25698-707. PubMed ID: 17595163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency.
    Mucka P; Levonyak N; Geretti E; Zwaans BMM; Li X; Adini I; Klagsbrun M; Adam RM; Bielenberg DR
    Am J Pathol; 2016 Nov; 186(11):2803-2812. PubMed ID: 27751443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2.
    Coma S; Allard-Ratick M; Akino T; van Meeteren LA; Mammoto A; Klagsbrun M
    Angiogenesis; 2013 Oct; 16(4):939-52. PubMed ID: 23892628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropilin-2 mediates lymphangiogenesis of colorectal carcinoma via a VEGFC/VEGFR3 independent signaling.
    Ou JJ; Wei X; Peng Y; Zha L; Zhou RB; Shi H; Zhou Q; Liang HJ
    Cancer Lett; 2015 Mar; 358(2):200-209. PubMed ID: 25543087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 3F and neuropilin-2 control the migration of human T-cell precursors.
    Mendes-da-Cruz DA; Brignier AC; Asnafi V; Baleydier F; Messias CV; Lepelletier Y; Bedjaoui N; Renand A; Smaniotto S; Canioni D; Milpied P; Balabanian K; Bousso P; LeprĂȘtre S; Bertrand Y; Dombret H; Ifrah N; Dardenne M; Macintyre E; Savino W; Hermine O
    PLoS One; 2014; 9(7):e103405. PubMed ID: 25068647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion.
    Nasarre P; Kusy S; Constantin B; Castellani V; Drabkin HA; Bagnard D; Roche J
    Neoplasia; 2005 Feb; 7(2):180-9. PubMed ID: 15802023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin-induced cytoskeletal collapse and repulsion of endothelial cells.
    Bielenberg DR; Shimizu A; Klagsbrun M
    Methods Enzymol; 2008; 443():299-314. PubMed ID: 18772022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
    Takata K; Morishige K; Takahashi T; Hashimoto K; Tsutsumi S; Yin L; Ohta T; Kawagoe J; Takahashi K; Kurachi H
    Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression.
    Futamura M; Kamino H; Miyamoto Y; Kitamura N; Nakamura Y; Ohnishi S; Masuda Y; Arakawa H
    Cancer Res; 2007 Feb; 67(4):1451-60. PubMed ID: 17308083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.
    Bielenberg DR; Hida Y; Shimizu A; Kaipainen A; Kreuter M; Kim CC; Klagsbrun M
    J Clin Invest; 2004 Nov; 114(9):1260-71. PubMed ID: 15520858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells.
    Kusy S; Nasarre P; Chan D; Potiron V; Meyronet D; Gemmill RM; Constantin B; Drabkin HA; Roche J
    Neoplasia; 2005 May; 7(5):457-65. PubMed ID: 15967098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.
    Coma S; Amin DN; Shimizu A; Lasorella A; Iavarone A; Klagsbrun M
    Cancer Res; 2010 May; 70(9):3823-32. PubMed ID: 20388805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
    Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
    Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semaphorin 3F Promotes Transendothelial Migration of Leukocytes in the Inflammatory Response After Survived Cardiac Arrest.
    Reichert S; Scheid S; Roth T; Herkel M; Petrova D; Linden A; Weberbauer M; Esser J; Diehl P; Grundmann S; Busch HJ; Fink K; Bode C; Moser M; Helbing T
    Inflammation; 2019 Aug; 42(4):1252-1264. PubMed ID: 30877507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.
    Guttmann-Raviv N; Shraga-Heled N; Varshavsky A; Guimaraes-Sternberg C; Kessler O; Neufeld G
    J Biol Chem; 2007 Sep; 282(36):26294-305. PubMed ID: 17569671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.